Tci Wealth Advisors, Inc. Revance Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$18.36 - $35.27 $6,077 - $11,674	331 New	331 $10,000
Q2 2022 Jul 19, 2022	SELL	$11.52 - $20.4 $3,075 - $5,446	-267 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$12.46 - $27.87 $1,470 - $3,288	118 Added 79.19%	267 $4,000
Q2 2021 Aug 02, 2021	BUY	$26.8 - $31.84 $107 - $127	4 Added 2.76%	149 $4,000
Q1 2021 Apr 29, 2021	BUY	$24.03 - $29.97 $3,484 - $4,345	145 New	145 $4,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.